Murat Haliloğlu
Murat Haliloğlu has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Beliz Bilgili
Department of Anesthesiology and Intensive Care, Marmara University School of Medicine, Istanbul, Turkey
3 shared publications - Mehmet Toptas
Univ Hlth Sci Turkey, Yedikule Chest Dis & Thorac Surg Training & Res H, Clin Anesthesiol, Istanbul, Turkey
3 shared publications - Ibrahim Akkoc
Department of Anesthesiology and Reanimation, Haseki Education and Research Hospital, Istanbul, Turkey
2 shared publications - Ismail Cinel
Department of Anaesthesiology and Reanimation, Marmara University Faculty of Medicine, İstanbul, Turkey
2 shared publications - İsMet Sayan
Clinic of Critical Care Medicine, Sancaktepe Training and Research Hospital, İstanbul, Türkiye
2 shared publications - Kemal Karapınar
Univ Hlth Sci Turkey, Yedikule Chest Dis & Thorac Surg Training & Res H, Clin Chest Surg, Istanbul, Turkey
2 shared publications
Latest Publications
- 24 May 2024
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 25 (2) , 165-169
Ketamine as a Supplementary Analgosedative in COVID-19 Patients on Mechanical Ventilation: A Single-Center Observational Study
- 24 May 2024
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 25 (2) , 165-169
Ketamine as a Supplementary Analgosedative in COVID-19 Patients on Mechanical Ventilation: A Single-Center Observational Study
- 1 August 2022
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 23 (3) , 205-209
Predicting Length of Stay and Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease at the Intensive Care Unit
- 1 August 2022
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 23 (3) , 205-209
Predicting Length of Stay and Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease at the Intensive Care Unit
- 1 February 2021
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 22 (1) , 13-18
Is Sarcopenia Related to Mortality in Patients with Chronic Obstructive Pulmonary Disease in the Intensive Care Unit?
- 1 February 2021
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 22 (1) , 13-18
Is Sarcopenia Related to Mortality in Patients with Chronic Obstructive Pulmonary Disease in the Intensive Care Unit?
- 27 September 2019
- Published by Galenos Yayinevi in Turkish Journal of Anaesthesiology and Reanimation
- Vol. 47 (5) , 367-374
The Role of Transcranial Doppler Ultrasonography in the Diagnosis of Brain Death
Ancillary tests can be used for the diagnosis of brain death in cases wherein uncertainty exists regarding the neurological examination and apnoea test cannot be performed. Transcranial Doppler ultrasonography (TCD) is a useful, valid, non-invasive, portable, and repeatable ancillary test for the confirmation of brain death. Despite its varying sensitivity and specificity rates with regard to the diagnosis of the brain death, its clinical use has steadily increased in the intensive care unit because of its numerous superior properties. The use of TCD as an ancillary test for the diagnosis of brain death and cerebral circulatory arrest is discussed in the current review.
- 27 September 2019
- Published by Galenos Yayinevi in Turkish Journal of Anaesthesiology and Reanimation
- Vol. 47 (5) , 367-374
The Role of Transcranial Doppler Ultrasonography in the Diagnosis of Brain Death
Ancillary tests can be used for the diagnosis of brain death in cases wherein uncertainty exists regarding the neurological examination and apnoea test cannot be performed. Transcranial Doppler ultrasonography (TCD) is a useful, valid, non-invasive, portable, and repeatable ancillary test for the confirmation of brain death. Despite its varying sensitivity and specificity rates with regard to the diagnosis of the brain death, its clinical use has steadily increased in the intensive care unit because of its numerous superior properties. The use of TCD as an ancillary test for the diagnosis of brain death and cerebral circulatory arrest is discussed in the current review.
- Open Access
- 26 March 2019
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 17 (1) , 38-43
Mekanik Ventilasyon Desteği Alan Kritik Hastalarda mNUTRIC Skor ile 28 Günlük Mortalite Arasındaki İlişki
Amaç: Kritik hastalarda beslenme risk durumunun 28 günlük mortalite üzerine etkisini araştırmayı amaçladık. Gereç ve Yöntem: Çalışmamız, 48 saatten fazla invaziv mekanik ventilasyon gereksinimi olan erişkin kritik hastalarda retrospektif yapıldı. Hastaların demografik verileri ve yatış günü, mNUTRIC (modified Nutritional Risk in Critically Ill) skoru kaydedildi. Enerji alımı ölüm, taburculuk veya 12. güne kadar günlük olarak kaydedildi. Hastalar a) günlük kalori ihtiyacının
- 26 March 2019
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 17 (1) , 38-43
Open AccessMekanik Ventilasyon Desteği Alan Kritik Hastalarda mNUTRIC Skor ile 28 Günlük Mortalite Arasındaki İlişki
Amaç: Kritik hastalarda beslenme risk durumunun 28 günlük mortalite üzerine etkisini araştırmayı amaçladık. Gereç ve Yöntem: Çalışmamız, 48 saatten fazla invaziv mekanik ventilasyon gereksinimi olan erişkin kritik hastalarda retrospektif yapıldı. Hastaların demografik verileri ve yatış günü, mNUTRIC (modified Nutritional Risk in Critically Ill) skoru kaydedildi. Enerji alımı ölüm, taburculuk veya 12. güne kadar günlük olarak kaydedildi. Hastalar a) günlük kalori ihtiyacının
- 24 September 2018
- Published by Galenos Yayinevi in Turkish Journal of Anaesthesiology and Reanimation
- Vol. 46 (5) , 373-380
Effect of the Dexamethasone-Ondansetron Combination Versus Dexamethasone-Aprepitant Combination to Prevent Postoperative Nausea and Vomiting
Objective: Postoperative nausea and vomiting (PONV) is a common problem associated with general anaesthesia. The incidence can be as high as 80% in high-risk patients. Our primary objective was to compare the efficacy of the combination of dexamethasone-ondansetron and dexamethasone-aprepitant in patients undergoing laparoscopic surgery. Methods: Seventy 18 to 60 years old patients scheduled for laparoscopic surgery were included in the study. Sixty-seven patients completed the study. Patients in the dexamethasone-aprepitant group (group DA, n=35) received 40 mg of aprepitant orally 1-2 hours before the induction of anaesthesia and 2 mL saline intravenously (iv) within the last 30 minutes of surgery; patients in the dexamethasone-ondansetron group (group DO, n=35) received oral placebo identical to aprepitant 1-2 hours before the induction of anaesthesia and 4 mg ondansetron iv within the last 30 minutes of surgery. All patients received 8 mg dexamethasone iv after the induction of anaesthesia. The primary outcome was a complete response (no postoperative nausea, retching and vomiting and no need for rescue antiemetic); the secondary outcomes were the incidence of nausea, retching, vomiting, the need of rescue antiemetic and opioid consumption within 24 hours after surgery. Results: A complete response was not significantly different between the groups (group DO: 67%, DA: 69%) at 24 hours (p=0.93). The incidence of PONV and postoperative opioid consumption was similar between the groups. Conclusion: The study was designed to evaluate whether the combination of dexamethasone-aprepitant is better than the combination of dexamethasone-ondansetron regarding the complete response for PONV in patients undergoing laparoscopic surgery. The results however showed that dexamethasone-aprepitant has not improved the complete response for PONV compared to dexamethasone-ondansetron.
- 24 September 2018
- Published by Galenos Yayinevi in Turkish Journal of Anaesthesiology and Reanimation
- Vol. 46 (5) , 373-380
Effect of the Dexamethasone-Ondansetron Combination Versus Dexamethasone-Aprepitant Combination to Prevent Postoperative Nausea and Vomiting
Objective: Postoperative nausea and vomiting (PONV) is a common problem associated with general anaesthesia. The incidence can be as high as 80% in high-risk patients. Our primary objective was to compare the efficacy of the combination of dexamethasone-ondansetron and dexamethasone-aprepitant in patients undergoing laparoscopic surgery. Methods: Seventy 18 to 60 years old patients scheduled for laparoscopic surgery were included in the study. Sixty-seven patients completed the study. Patients in the dexamethasone-aprepitant group (group DA, n=35) received 40 mg of aprepitant orally 1-2 hours before the induction of anaesthesia and 2 mL saline intravenously (iv) within the last 30 minutes of surgery; patients in the dexamethasone-ondansetron group (group DO, n=35) received oral placebo identical to aprepitant 1-2 hours before the induction of anaesthesia and 4 mg ondansetron iv within the last 30 minutes of surgery. All patients received 8 mg dexamethasone iv after the induction of anaesthesia. The primary outcome was a complete response (no postoperative nausea, retching and vomiting and no need for rescue antiemetic); the secondary outcomes were the incidence of nausea, retching, vomiting, the need of rescue antiemetic and opioid consumption within 24 hours after surgery. Results: A complete response was not significantly different between the groups (group DO: 67%, DA: 69%) at 24 hours (p=0.93). The incidence of PONV and postoperative opioid consumption was similar between the groups. Conclusion: The study was designed to evaluate whether the combination of dexamethasone-aprepitant is better than the combination of dexamethasone-ondansetron regarding the complete response for PONV in patients undergoing laparoscopic surgery. The results however showed that dexamethasone-aprepitant has not improved the complete response for PONV compared to dexamethasone-ondansetron.
- 15 May 2018
- Published by Galenos Yayinevi in Turkish Journal of Anesthesia and Reanimation
- Vol. 46 (1) , 38-43
Diagnostic Accuracy of Procalcitonin for Differentiating Bacteraemic Gram-Negative Sepsis from Gram-Positive Sepsis
The identification of bacteraemia in patients with suspected sepsis is crucial for survival. A cheap, fast and reliable biomarker, which can predict the causative pathogen group, may be useful to confirm or exclude the presence of bacteraemia. This study aimed to evaluate the relationship between procalcitonin (PCT) and the causative pathogen in intensive care patients with sepsis and bacteraemia. Patients with diagnosed sepsis, a positive blood culture and measured serum procalcitonin levels during their intensive care unit stay were included in the study. Demographic data, PCT level, leukocyte count, C-reactive protein level, creatinine level, lymphocyte count, leukocyte/lymphocyte ratio and the group of the pathogen that detected in the blood culture were retrospectively recorded. Overall, 136 sepsis patients who were diagnosed with bacteraemia were included in the study. The PCT level was 7.31 ng mL-1 in the gram-negative group and 0.46 ng mL-1 in the gram-positive group. For PCT, the sensitivity was 70.83% and the specificity was 84.21%, with the cut-off value being ≤1.3. The area under the receiver operating characteristics curve for PCT was 0.80. Patients with gram-negative sepsis had higher PCT values than those with gram-positive sepsis. Our results suggest that PCT value may be a useful tool for distinguishing between gram-negative and gram-positive bacteraemia.
- 15 May 2018
- Published by Galenos Yayinevi in Turkish Journal of Anesthesia and Reanimation
- Vol. 46 (1) , 38-43
Diagnostic Accuracy of Procalcitonin for Differentiating Bacteraemic Gram-Negative Sepsis from Gram-Positive Sepsis
The identification of bacteraemia in patients with suspected sepsis is crucial for survival. A cheap, fast and reliable biomarker, which can predict the causative pathogen group, may be useful to confirm or exclude the presence of bacteraemia. This study aimed to evaluate the relationship between procalcitonin (PCT) and the causative pathogen in intensive care patients with sepsis and bacteraemia. Patients with diagnosed sepsis, a positive blood culture and measured serum procalcitonin levels during their intensive care unit stay were included in the study. Demographic data, PCT level, leukocyte count, C-reactive protein level, creatinine level, lymphocyte count, leukocyte/lymphocyte ratio and the group of the pathogen that detected in the blood culture were retrospectively recorded. Overall, 136 sepsis patients who were diagnosed with bacteraemia were included in the study. The PCT level was 7.31 ng mL-1 in the gram-negative group and 0.46 ng mL-1 in the gram-positive group. For PCT, the sensitivity was 70.83% and the specificity was 84.21%, with the cut-off value being ≤1.3. The area under the receiver operating characteristics curve for PCT was 0.80. Patients with gram-negative sepsis had higher PCT values than those with gram-positive sepsis. Our results suggest that PCT value may be a useful tool for distinguishing between gram-negative and gram-positive bacteraemia.